Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
about
Impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirinComparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs.Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers.
P2860
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@ast
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@en
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@nl
type
label
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@ast
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@en
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@nl
prefLabel
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@ast
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@en
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@nl
P2093
P2860
P1433
P1476
Aspirin under fire: aspirin use in the primary prevention of coronary heart disease
@en
P2093
Abdul-Karim Elhabyan
B Daniel Lucas
Michael G Miller
Vasilios Papademetriou
P2860
P304
P356
10.1592/PHCO.2005.25.6.847
P407
P577
2005-06-01T00:00:00Z